Back to NATIONAL BANK OF CANADA /FI/ NATIONAL BANK OF CANADA /FI/

VRAXVRAX
4 quarters

Position history for NATIONAL BANK OF CANADA /FI/NATIONAL BANK OF CANADA /FI/'s holdings in VIRAX BIOLABS GROUP LTD

NATIONAL BANK OF CANADA /FI/ previously held 0 shares of VRAX (VIRAX BIOLABS GROUP LTD), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$3,950

Total Shares Change

-5,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.20
0
2025-Q4
Decreased
6,000
-40.0%
$2,0700.0%$0.35
0
2025-Q3
Increased
10,000
+100.0%
$6,0000.0%$0.60
17
2025-Q2
New
5,000
-
$3,9500.0%$0.78
22

Other major holders of VRAX: RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Squarepoint Ops LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used